Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
The Prostate
|
May 5, 2024
The additional value of <sup>68</sup>Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy
Joris G Heetman, Leonor J Paulino Pereira, Johannes C Kelder, et al.
Annals of Surgical Oncology
|
February 5, 2026
ASO Visual Abstract: The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate Our Former Strategy? Reevaluating the Role of Internal Mammary Sentinel Node Removal in Breast Cancer Surgery
Emilie M A L C Fentener van Vlissingen, Emily L Postma, Astrid N Scholten, et al.
Annals of Surgical Oncology
|
January 4, 2026
The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate our Former Strategy?
Emilie M A L C Fentener van Vlissingen, Emily L Postma, Astrid N Scholten, et al.
The Journal of Urology
|
December 4, 2019
Reply by Authors
Ludwike W M van Kalmthout, Harm H E van Melick, Jules Lavalaye, et al.
The Journal of Urology
|
September 6, 2019
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer
Ludwike W M van Kalmthout, Harm H E van Melick, Jules Lavalaye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2019
Healthy Tissue Uptake of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen, <sup>18</sup>F-DCFPyL, <sup>18</sup>F-Fluoromethylcholine, and <sup>18</sup>F-Dihydrotestosterone
Bernard H E Jansen, Gem M Kramer, Matthijs C F Cysouw, et al.
Scientific Reports
|
April 11, 2025
The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer
Tessa van Elst, Niven Mehra, Sjaak Bloem, et al.
Critical Care (London, England)
|
April 10, 2026
Determinants of diagnostic yield and scan quality of [<sup>18</sup>F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin
Jelle L G Haitsma Mulier, Bram van Leer, Joanne J Beijer-Verduin, et al.
Clinical Genitourinary Cancer
|
December 1, 2021
Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands
Malou C P Kuppen, Hans M Westgeest, Alfons J M van den Eertwegh, et al.
Future Oncology (London, England)
|
May 30, 2020
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
Malou Cp Kuppen, Hans M Westgeest, Maarten J van der Doelen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
The Prostate
|
May 5, 2024
The additional value of <sup>68</sup>Ga-PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy
Joris G Heetman, Leonor J Paulino Pereira, Johannes C Kelder, et al.
Annals of Surgical Oncology
|
February 5, 2026
ASO Visual Abstract: The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate Our Former Strategy? Reevaluating the Role of Internal Mammary Sentinel Node Removal in Breast Cancer Surgery
Emilie M A L C Fentener van Vlissingen, Emily L Postma, Astrid N Scholten, et al.
Annals of Surgical Oncology
|
January 4, 2026
The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate our Former Strategy?
Emilie M A L C Fentener van Vlissingen, Emily L Postma, Astrid N Scholten, et al.
The Journal of Urology
|
December 4, 2019
Reply by Authors
Ludwike W M van Kalmthout, Harm H E van Melick, Jules Lavalaye, et al.
The Journal of Urology
|
September 6, 2019
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer
Ludwike W M van Kalmthout, Harm H E van Melick, Jules Lavalaye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 12, 2019
Healthy Tissue Uptake of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen, <sup>18</sup>F-DCFPyL, <sup>18</sup>F-Fluoromethylcholine, and <sup>18</sup>F-Dihydrotestosterone
Bernard H E Jansen, Gem M Kramer, Matthijs C F Cysouw, et al.
Scientific Reports
|
April 11, 2025
The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer
Tessa van Elst, Niven Mehra, Sjaak Bloem, et al.
Critical Care (London, England)
|
April 10, 2026
Determinants of diagnostic yield and scan quality of [<sup>18</sup>F]FDG PET/CT in critically ill patients suspected of infection or inflammation of unknown origin
Jelle L G Haitsma Mulier, Bram van Leer, Joanne J Beijer-Verduin, et al.
Clinical Genitourinary Cancer
|
December 1, 2021
Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands
Malou C P Kuppen, Hans M Westgeest, Alfons J M van den Eertwegh, et al.
Future Oncology (London, England)
|
May 30, 2020
Real-world outcomes of radium-223 dichloride for metastatic castration resistant prostate cancer
Malou Cp Kuppen, Hans M Westgeest, Maarten J van der Doelen, et al.
Page
of 4